hydroquinone has been researched along with B16 Melanoma in 7 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Arbutin (Arb) and deoxyArbutin (dA) are both effective hypopigmentation agents." | 7.85 | Study of Hydroquinone Mediated Cytotoxicity and Hypopigmentation Effects from UVB-Irradiated Arbutin and DeoxyArbutin. ( Chang, NF; Chen, AN; Chen, YS; Huang, CH; Lin, CC; Lin, YJ; Tai, TH, 2017) |
| "Arbutin (Arb) and deoxyArbutin (dA) are both effective hypopigmentation agents." | 3.85 | Study of Hydroquinone Mediated Cytotoxicity and Hypopigmentation Effects from UVB-Irradiated Arbutin and DeoxyArbutin. ( Chang, NF; Chen, AN; Chen, YS; Huang, CH; Lin, CC; Lin, YJ; Tai, TH, 2017) |
| " We postulated that the TRP-2 beneficial effect observed in WM35 cells in the oxidative stress situation may relate to quinone metabolization and, more precisely, to the ability of TRP-2 to clear off related toxic metabolites, resulting in a global redox status modification." | 1.35 | TRP-2 expression protects HEK cells from dopamine- and hydroquinone-induced toxicity. ( Alleaume, AM; Bernard, BA; Commo, S; El Houari, F; Ito, S; Michard, Q; Rocchetti, J; Wakamatsu, K, 2008) |
| "Treatment with glycine (1-16 mM) for 72 h inhibited alpha-melanocyte stimulating hormone (alpha-MSH)-induced melanogenesis in a concentration-dependent manner without any effects on cell proliferation in B16F0 melanoma cells." | 1.34 | Glycine inhibits melanogenesis in vitro and causes hypopigmentation in vivo. ( Ishii, F; Ishikawa, M; Kawase, I, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, J | 1 |
| Bae, SJ | 1 |
| Ha, YM | 2 |
| No, JK | 1 |
| Lee, EK | 1 |
| Lee, JS | 1 |
| Song, S | 2 |
| Lee, H | 2 |
| Suh, H | 2 |
| Yu, BP | 1 |
| Chung, HY | 2 |
| Chang, NF | 1 |
| Chen, YS | 1 |
| Lin, YJ | 1 |
| Tai, TH | 1 |
| Chen, AN | 1 |
| Huang, CH | 1 |
| Lin, CC | 1 |
| Byeon, SE | 1 |
| Yi, YS | 1 |
| Lee, J | 1 |
| Yang, WS | 1 |
| Kim, JH | 2 |
| Kim, J | 1 |
| Hong, S | 1 |
| Cho, JY | 1 |
| Michard, Q | 1 |
| Commo, S | 1 |
| Rocchetti, J | 1 |
| El Houari, F | 1 |
| Alleaume, AM | 1 |
| Wakamatsu, K | 1 |
| Ito, S | 1 |
| Bernard, BA | 1 |
| Candan, G | 1 |
| Michiue, H | 1 |
| Ishikawa, S | 1 |
| Fujimura, A | 1 |
| Hayashi, K | 1 |
| Uneda, A | 1 |
| Mori, A | 1 |
| Ohmori, I | 1 |
| Nishiki, T | 1 |
| Matsui, H | 1 |
| Tomizawa, K | 1 |
| Chung, SW | 1 |
| Ishikawa, M | 1 |
| Kawase, I | 1 |
| Ishii, F | 1 |
7 other studies available for hydroquinone and B16 Melanoma
| Article | Year |
|---|---|
A newly synthesized, potent tyrosinase inhibitor: 5-(6-hydroxy-2-naphthyl)-1,2,3-benzenetriol.
Topics: Agaricales; Animals; Enzyme Inhibitors; Kinetics; Melanins; Melanoma, Experimental; Mice; Monophenol | 2010 |
Study of Hydroquinone Mediated Cytotoxicity and Hypopigmentation Effects from UVB-Irradiated Arbutin and DeoxyArbutin.
Topics: Animals; Arbutin; Caspase 3; Cell Survival; Cells, Cultured; Fibroblasts; Glucosides; Humans; Hydroq | 2017 |
Hydroquinone Exhibits In Vitro and In Vivo Anti-Cancer Activity in Cancer Cells and Mice.
Topics: Animals; Antineoplastic Agents; Azoxymethane; Benzoquinones; Cell Line, Tumor; Cell Proliferation; C | 2018 |
TRP-2 expression protects HEK cells from dopamine- and hydroquinone-induced toxicity.
Topics: Blotting, Western; Cell Line, Tumor; Cell Survival; Dopamine; Gene Expression Profiling; Humans; Hyd | 2008 |
Combining poly-arginine with the hydrophobic counter-anion 4-(1-pyrenyl)-butyric acid for protein transduction in transdermal delivery.
Topics: Administration, Cutaneous; Animals; Anions; Butyric Acid; Cell Survival; Drug Delivery Systems; Gree | 2012 |
4-(6-Hydroxy-2-naphthyl)-1,3-bezendiol: a potent, new tyrosinase inhibitor.
Topics: Agaricales; Animals; Cell Survival; Dose-Response Relationship, Drug; Enzyme Inhibitors; Hydroquinon | 2007 |
Glycine inhibits melanogenesis in vitro and causes hypopigmentation in vivo.
Topics: alpha-MSH; Amino Acids; Animals; Antioxidants; Cell Line, Tumor; Dose-Response Relationship, Drug; F | 2007 |